Condition
Neoplastic Syndromes, Hereditary
Total Trials
5
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Enrolling By Invitation1
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07053813Not ApplicableEnrolling By InvitationPrimary
Applying Population Management Best Practices to Preventative Genomic Medicine Trial
NCT05079334Active Not RecruitingPrimary
Family History and Cancer Risk Study
NCT04903782RecruitingPrimary
Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
NCT00001377CompletedPrimary
Familial Prostate Cancer
NCT00001814CompletedPrimary
Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples
Showing all 5 trials